Zimbabwe has rejected a substantial American health deal worth 367 million US dollars (£272m) over five years because of the United States' request for confidential biological samples.
This rejection became public after a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
An official spokesperson has since stated that the United States was requesting genetic material for research and profit while was unwilling to guarantee the resulting advantages from future vaccines.
"We must now begin the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for further negotiations to find a deal acceptable to both sides so the nation's vital HIV programme can continue.
Wider Context
This rejection comes after a similar case in Kenya, where a high court blocked a similar health funding agreement after legal challenges were raised about the security of citizens' medical information.
After returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump claimed its spending was "wasteful" and his government was pursuing government-to-government deals to enhance openness and responsibility.
According to statements, 16 African countries have to date agreed to similar agreements, constituting more than $18.3bn in committed funds.
Details of the Declined Agreement
The money for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million currently receiving HIV treatment through US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, with no equivalent guarantee of access to any medical innovations – such as new medicines or tests – that might be developed from that shared data," Mangwana explained.
"Effectively, our nation would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be accessible to our population if a future pandemic arise."
Sovereignty and International Frameworks
He also noted that the US's withdrawal from the global health body and its push of one-on-one deals were disrupting systems previously established via the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.
"This framework is designed to ensure that when a country contributes its samples, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome further discussions with our American counterparts on how future collaboration might be structured in a way that respects the independence and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but recommended that negotiations must proceed since much of the nation's Aids initiatives depended on external financing.
"If technical issues exist, including those relating to information security or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," it said.
The situation underscores the complex challenges between receiving vital foreign assistance and safeguarding a country's data in an ever more interconnected world.